Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000480801 | SCV000570239 | likely pathogenic | not provided | 2016-05-09 | criteria provided, single submitter | clinical testing | The W23386X variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. W23386X is predicted to cause loss of normal protein function either due to production of an abnormal, prematurely truncated protein, or by absence of protein product due to nonsense mediated mRNA decay. Other truncating TTN variants have been reported in approximately 3% of control alleles (Herman et al., 2012). However, W23386X is located in the A-band region of titin, where the majority of truncating pathogenic variants associated with DCM have been reported (Herman et al., 2012). Furthermore, W23386X was not observed in approximately 6,100 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. In summary, W23386X in the TTN gene is expected to be pathogenic, however the possibility it may be a rare benign variant cannot be excluded. |